Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Legionellosis (mmu05134)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Apaf1
KLA  ATP  ATP+KLA
 NM_001042558 apoptotic peptidase activating factor 1 (Apaf1), transcript variant 1, mRNA [NM_001042558] KLA 2.92 2.81 3.22 2.74 2.42 1.74 1.40
ATP 1.05 .99 .87 .81 1.61 2.03 1.46
KLA/ATP 2.90 2.78 2.01 1.69 1.56 2.77 2.73
Arf1
KLA  ATP  ATP+KLA
 NM_007476 ADP-ribosylation factor 1 (Arf1), mRNA [NM_007476] KLA 1.09 1.20 1.18 1.14 1.26 1.31 1.28
ATP 1.05 1.19 .94 1.23 1.10 .97 1.18
KLA/ATP 1.22 1.22 .94 1.36 1.07 1.16 1.29
Bcl2l13
KLA  ATP  ATP+KLA
 NM_153516 BCL2-like 13 (apoptosis facilitator) (Bcl2l13), nuclear gene encoding mitochondrial protein, mRNA [NM_153516] KLA .82 .88 .83 .75 .78 1.00 1.48
ATP 1.01 1.07 1.06 1.10 .84 1.30 1.52
KLA/ATP .83 .86 .78 .83 .70 1.60 2.37
Birc1f
KLA  ATP  ATP+KLA
 NM_010871 baculoviral IAP repeat-containing 1f (Birc1f), mRNA [NM_010871] KLA 1.23 1.26 1.49 1.28 1.40 1.41 1.45
ATP 1.18 1.18 1.05 1.15 .78 .76 1.02
KLA/ATP 1.49 1.45 1.18 1.27 .75 .94 1.14
Bnip3
KLA  ATP  ATP+KLA
 NM_009760 BCL2/adenovirus E1B interacting protein 1, NIP3 (Bnip3), nuclear gene encoding mitochondrial protein, mRNA [NM_009760] KLA .90 1.03 .99 .91 1.00 1.23 1.94
ATP .99 1.01 1.09 1.08 1.01 1.56 .98
KLA/ATP .89 .95 .93 1.19 1.26 1.15 1.86
C3
KLA  ATP  ATP+KLA
 NM_009778 complement component 3 (C3), mRNA [NM_009778] KLA 28.58 25.57 24.39 27.34 23.38 23.21 18.10
ATP 1.04 .93 1.21 1.90 2.80 5.74 12.19
KLA/ATP 27.04 26.10 33.29 23.09 25.65 23.77 40.22
Casp1
KLA  ATP  ATP+KLA
 NM_009807 caspase 1 (Casp1), mRNA [NM_009807] KLA 4.27 4.63 5.39 6.07 5.87 5.49 2.96
ATP .93 .87 1.01 .80 1.05 3.11 2.77
KLA/ATP 4.31 4.18 5.40 4.00 4.66 4.90 7.20
Casp3
KLA  ATP  ATP+KLA
 NM_009810 caspase 3 (Casp3), mRNA [NM_009810] KLA 1.66 1.94 2.47 2.61 3.01 2.96 1.44
ATP .90 .99 1.17 1.30 1.01 1.17 .86
KLA/ATP 1.55 1.87 2.40 2.35 2.27 2.84 2.52
Casp3
KLA  ATP  ATP+KLA
 U49929 ICE-like cysteine protease (Lice) mRNA, complete cds. [U49929] KLA 1.71 1.87 2.69 3.11 3.64 3.42 1.52
ATP 1.04 1.07 1.16 1.34 .98 1.27 .86
KLA/ATP 1.80 1.96 2.46 2.91 2.50 3.24 3.10
Casp7
KLA  ATP  ATP+KLA
 NM_007611 caspase 7 (Casp7), mRNA [NM_007611] KLA 3.50 3.60 4.52 5.05 5.20 2.96 1.27
ATP 1.03 1.14 1.20 1.27 .82 .77 .84
KLA/ATP 3.32 3.86 3.98 5.27 3.49 2.55 2.30
Casp8
KLA  ATP  ATP+KLA
 NM_009812 caspase 8 (Casp8), transcript variant 1, mRNA [NM_009812] KLA 2.41 2.53 3.20 3.26 2.75 2.78 1.57
ATP .91 .96 .66 .67 .54 1.53 1.52
KLA/ATP 2.47 2.52 2.08 2.41 1.41 2.50 2.77
Casp9
KLA  ATP  ATP+KLA
 NM_015733 caspase 9 (Casp9), mRNA [NM_015733] KLA .31 .31 .40 .66 .89 1.19 .91
ATP .88 .77 .91 .59 .43 .75 .93
KLA/ATP .26 .26 .30 .28 .80 1.06 .97
Cd14
KLA  ATP  ATP+KLA
 NM_009841 CD14 antigen (Cd14), mRNA [NM_009841] KLA 2.35 2.68 2.54 2.21 2.39 1.52 1.57
ATP 1.44 2.28 2.82 3.98 6.68 16.14 6.92
KLA/ATP 2.92 3.79 3.96 5.12 5.29 10.42 11.50
Clk1
KLA  ATP  ATP+KLA
 NM_001042634 CDC-like kinase 1 (Clk1), transcript variant 1, mRNA [NM_001042634] KLA 1.03 1.03 1.02 .95 1.01 .90 .88
ATP 1.46 2.04 2.62 2.08 2.08 .97 .81
KLA/ATP 1.17 1.61 1.92 1.80 2.08 1.12 1.04
Cxcl1
KLA  ATP  ATP+KLA
 NM_008176 chemokine (C-X-C motif) ligand 1 (Cxcl1), mRNA [NM_008176] KLA 36.87 30.25 15.74 8.84 5.41 3.01 5.84
ATP 2.77 8.26 128.38 289.44 262.38 218.83 26.91
KLA/ATP 41.06 56.76 91.82 164.83 91.44 77.89 79.05
Cxcl2
KLA  ATP  ATP+KLA
 NM_009140 chemokine (C-X-C motif) ligand 2 (Cxcl2), mRNA [NM_009140] KLA 20.11 17.63 13.50 7.78 9.14 3.98 10.85
ATP 10.96 27.84 145.37 396.18 303.88 165.35 21.04
KLA/ATP 33.28 74.00 189.99 348.56 93.84 68.75 64.87
Cxcl3
KLA  ATP  ATP+KLA
 NM_203320 chemokine (C-X-C motif) ligand 3 (Cxcl3), mRNA [NM_203320] KLA 35.82 43.91 31.09 16.74 3.98 2.27 2.93
ATP 1.13 1.23 3.43 12.43 126.40 310.60 215.03
KLA/ATP 36.32 44.70 46.93 50.61 18.91 95.89 296.64
Cycs
KLA  ATP  ATP+KLA
 NM_007808 cytochrome c, somatic (Cycs), nuclear gene encoding mitochondrial protein, mRNA [NM_007808] KLA 2.20 2.21 2.35 2.69 2.62 3.22 2.14
ATP .87 .89 1.31 1.05 1.06 1.20 1.26
KLA/ATP 1.88 2.04 2.86 2.26 2.57 2.45 2.03
Cyct
KLA  ATP  ATP+KLA
 NM_009989 cytochrome c, testis (Cyct), mRNA [NM_009989] KLA .93 1.01 1.00 .99 1.02 1.03 .96
ATP 1.01 .91 1.01 .99 .98 .95 .95
KLA/ATP 1.10 .96 .89 .89 1.10 1.05 .97
Eef1a1
KLA  ATP  ATP+KLA
 NM_010106 eukaryotic translation elongation factor 1 alpha 1 (Eef1a1), mRNA [NM_010106] KLA .99 1.05 .96 .85 .88 .67 .57
ATP 1.05 1.05 .97 .96 .94 .82 .56
KLA/ATP .96 .90 .88 .87 .69 .53 .34
Eef1a2
KLA  ATP  ATP+KLA
 NM_007906 eukaryotic translation elongation factor 1 alpha 2 (Eef1a2), mRNA [NM_007906] KLA .96 .97 .92 .99 .88 .80 .87
ATP 1.03 1.13 .98 1.05 .96 .98 1.72
KLA/ATP .95 1.02 .89 1.01 .85 1.27 1.76
Eef1g
KLA  ATP  ATP+KLA
 AK011951 10 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2610301D06 product:ELONGATION FACTOR 1-GAMMA (EF-1-GAMMA) (EEF-1B GAMMA) homolog [Mus musculus], full insert sequence [AK011951] KLA .90 .88 .63 .79 .52 .44 .76
ATP 1.14 1.15 1.30 1.18 1.00 .37 .54
KLA/ATP .81 .93 .98 .88 .63 .29 .20
Eef1g
KLA  ATP  ATP+KLA
 NM_026007 eukaryotic translation elongation factor 1 gamma (Eef1g), mRNA [NM_026007] KLA .84 .86 .87 .73 .73 .63 .78
ATP 1.02 1.05 .87 .81 .87 .69 .52
KLA/ATP .97 .95 .76 .68 .64 .51 .33
Hbs1l
KLA  ATP  ATP+KLA
 NM_019702 Hbs1-like (S. cerevisiae) (Hbs1l), transcript variant 1, mRNA [NM_019702] KLA 1.22 1.17 1.11 1.16 1.10 1.04 1.07
ATP .93 .94 1.03 .92 1.21 1.46 .91
KLA/ATP 1.09 1.12 1.21 1.00 1.19 1.30 .99
Hsf1
KLA  ATP  ATP+KLA
 NM_008296 heat shock factor 1 (Hsf1), mRNA [NM_008296] KLA .95 .89 .86 .75 .82 .78 1.11
ATP 1.17 1.16 1.05 1.17 1.06 .96 .95
KLA/ATP 1.12 1.03 .85 .95 .73 .62 .62
Hsf1
KLA  ATP  ATP+KLA
 Z49206 gb|M.musculus mRNA for heat shock factor 1-alpha. [Z49206] KLA 1.08 1.12 1.13 1.02 1.11 1.08 1.06
ATP 1.01 1.13 1.01 1.29 1.20 1.04 1.14
KLA/ATP 1.15 1.18 1.12 1.35 1.20 1.17 1.32
Hspa1a
KLA  ATP  ATP+KLA
 NM_010479 heat shock protein 1A (Hspa1a), mRNA [NM_010479] KLA 7.88 6.99 4.47 5.18 7.81 11.47 4.14
ATP 1.88 5.62 43.42 58.76 55.53 28.89 9.13
KLA/ATP 7.40 7.62 28.23 54.12 70.14 43.09 22.49
Hspa1b
KLA  ATP  ATP+KLA
 NM_010478 heat shock protein 1B (Hspa1b), mRNA [NM_010478] KLA 5.01 4.73 3.77 3.62 4.81 6.53 3.12
ATP 1.34 3.07 14.11 17.14 17.51 11.21 4.82
KLA/ATP 5.04 5.15 11.63 19.94 20.84 15.79 9.30
Hspa1l
KLA  ATP  ATP+KLA
 NM_013558 heat shock protein 1-like (Hspa1l), mRNA [NM_013558] KLA .98 1.04 1.10 1.21 1.51 1.97 1.86
ATP 1.03 1.08 1.07 1.14 .93 1.21 1.89
KLA/ATP 1.06 1.01 .99 1.09 .97 1.39 2.87
Hspa2
KLA  ATP  ATP+KLA
 NM_008301 heat shock protein 2 (Hspa2), transcript variant 1, mRNA [NM_008301] KLA .98 .97 1.12 1.23 1.20 1.72 1.38
ATP 1.01 1.10 1.45 3.12 2.45 1.98 .98
KLA/ATP .99 1.12 1.52 2.60 2.89 2.62 1.18
Hspa8
KLA  ATP  ATP+KLA
 NM_031165 heat shock protein 8 (Hspa8), mRNA [NM_031165] KLA 1.00 .98 1.27 1.18 1.45 1.60 1.31
ATP 1.22 1.18 1.07 1.44 1.07 .53 .57
KLA/ATP 1.18 1.22 1.14 1.08 .93 .82 .77
Hspd1
KLA  ATP  ATP+KLA
 NM_010477 heat shock protein 1 (chaperonin) (Hspd1), nuclear gene encoding mitochondrial protein, mRNA [NM_010477] KLA .86 .89 .76 .67 .65 .60 .91
ATP 1.12 1.15 .98 .92 .91 .71 .64
KLA/ATP .86 .97 .82 .74 .56 .38 .34
Il12a
KLA  ATP  ATP+KLA
 NM_008351 interleukin 12a (Il12a), mRNA [NM_008351] KLA 2.37 2.47 2.17 1.49 1.46 1.12 1.20
ATP 1.01 .97 1.12 1.07 1.02 1.07 1.06
KLA/ATP 2.01 2.76 2.54 1.70 1.08 1.10 1.27
Il12b
KLA  ATP  ATP+KLA
 NM_008352 interleukin 12b (Il12b), mRNA [NM_008352] KLA 194.79 211.32 198.97 173.01 142.24 40.28 3.10
ATP 1.05 1.10 1.59 1.99 2.71 2.72 1.52
KLA/ATP 191.27 223.23 280.10 224.29 183.03 68.43 10.69
Il18
KLA  ATP  ATP+KLA
 NM_008360 interleukin 18 (Il18), mRNA [NM_008360] KLA 12.14 11.96 12.28 12.96 12.23 7.84 2.40
ATP 1.06 .96 1.13 1.04 .92 1.67 2.29
KLA/ATP 11.55 11.63 13.03 9.98 9.08 6.50 6.72
Il1b
KLA  ATP  ATP+KLA
 NM_008361 interleukin 1 beta (Il1b), mRNA [NM_008361] KLA 149.78 133.59 100.91 116.58 86.48 89.37 64.72
ATP 3.49 13.96 61.44 70.91 82.12 162.79 28.18
KLA/ATP 130.32 139.00 219.12 148.17 165.44 172.57 146.98
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Itgam
KLA  ATP  ATP+KLA
 NM_001082960 integrin alpha M (Itgam), transcript variant 1, mRNA [NM_001082960] KLA 1.04 1.12 1.14 1.07 1.54 1.80 1.72
ATP 1.17 1.19 .97 1.16 .86 .65 1.33
KLA/ATP 1.19 1.19 .94 1.06 .64 .59 1.08
Itgam
KLA  ATP  ATP+KLA
 NM_008401 integrin alpha M (Itgam), transcript variant 2, mRNA [NM_008401] KLA 1.20 1.16 1.21 1.34 1.59 1.79 1.64
ATP 1.15 1.16 .94 1.20 1.00 .78 1.25
KLA/ATP 1.32 1.37 1.29 1.14 .84 .75 1.16
Itgb2
KLA  ATP  ATP+KLA
 NM_008404 integrin beta 2 (Itgb2), mRNA [NM_008404] KLA .78 .78 .97 .74 1.04 .94 1.14
ATP 1.24 1.23 .79 .95 1.12 .84 1.10
KLA/ATP .99 1.01 .60 .83 .78 .73 .99
Itgb2l
KLA  ATP  ATP+KLA
 NM_008405 integrin beta 2-like (Itgb2l), mRNA [NM_008405] KLA .87 .98 .98 1.00 1.05 1.07 1.10
ATP 1.24 1.23 1.13 1.14 1.29 1.05 1.05
KLA/ATP 1.02 1.08 1.08 1.06 .98 .93 .95
Mm.11689
4
KLA  ATP  ATP+KLA
 124248589 Unknown KLA .85 .82 .79 .95 .77 .84 .58
ATP 1.04 1.03 .99 .93 .82 .79 .78
KLA/ATP .92 .86 .85 .79 .78 .79 .64
Mm.31188
4
KLA  ATP  ATP+KLA
 146198620 Unknown KLA .69 .70 .77 1.02 1.29 2.04 1.80
ATP .91 .82 .91 .83 1.09 2.72 1.14
KLA/ATP .65 .57 .81 .73 .88 2.07 3.86
Mm.38049
KLA  ATP  ATP+KLA
 118130391 Unknown KLA .67 .65 .73 .92 .63 .81 .76
ATP .93 .92 1.08 .54 .45 1.48 1.56
KLA/ATP .57 .65 .98 .67 .44 .78 1.16
Mm.41274
5
KLA  ATP  ATP+KLA
 110681696 Unknown KLA .97 1.07 1.11 1.07 1.38 1.63 1.35
ATP 1.06 1.09 1.05 1.29 1.04 .50 .56
KLA/ATP 1.11 1.12 1.04 1.11 .92 .83 .74
Mm.6898
KLA  ATP  ATP+KLA
 114431261 Unknown KLA 1.64 1.74 1.72 2.04 2.10 3.30 4.37
ATP .91 .89 1.30 1.30 1.20 1.74 2.92
KLA/ATP 1.55 1.79 2.35 1.74 2.10 4.16 7.14
Myd88
KLA  ATP  ATP+KLA
 NM_010851 myeloid differentiation primary response gene 88 (Myd88), mRNA [NM_010851] KLA 3.35 3.51 3.91 4.13 4.13 3.62 2.53
ATP .99 .96 .79 .75 .93 2.15 1.60
KLA/ATP 3.37 3.52 3.52 3.48 2.81 3.03 3.33
Naip1
KLA  ATP  ATP+KLA
 NM_008670 NLR family, apoptosis inhibitory protein 1 (Naip1), mRNA [NM_008670] KLA .99 .97 1.00 .97 .95 1.23 2.04
ATP 1.01 1.01 .99 1.10 .96 1.05 1.13
KLA/ATP 1.00 .99 1.00 .96 .99 1.51 2.34
Naip2
KLA  ATP  ATP+KLA
 NM_010872 NLR family, apoptosis inhibitory protein 2 (Naip2), transcript variant 1, mRNA [NM_010872] KLA 1.34 1.30 1.51 1.87 2.03 2.04 2.38
ATP 1.23 1.14 1.07 .78 1.36 4.78 1.82
KLA/ATP 1.53 1.56 1.46 1.11 1.50 4.78 5.42
Naip5
KLA  ATP  ATP+KLA
 NM_010870 NLR family, apoptosis inhibitory protein 5 (Naip5), mRNA [NM_010870] KLA 1.26 1.22 1.40 1.37 1.81 2.01 1.38
ATP 1.00 .96 1.17 1.14 .84 1.12 .95
KLA/ATP 1.27 1.29 1.57 1.38 1.60 2.00 1.76
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nfkb2
KLA  ATP  ATP+KLA
 NM_019408 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 (Nfkb2), mRNA [NM_019408] KLA 7.31 7.92 7.95 6.42 6.41 4.42 2.81
ATP .99 .98 .72 1.48 2.80 5.31 1.44
KLA/ATP 8.25 7.93 6.51 7.68 5.08 4.38 4.86
Nfkbia
KLA  ATP  ATP+KLA
 NM_010907 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia), mRNA [NM_010907] KLA 18.65 18.46 13.63 17.88 14.25 9.17 7.92
ATP .91 1.09 7.11 32.39 17.44 10.49 1.72
KLA/ATP 15.57 17.66 15.73 23.91 13.83 10.73 9.48
Nlrc4
KLA  ATP  ATP+KLA
 NM_001033367 NLR family, CARD domain containing 4 (Nlrc4), mRNA [NM_001033367] KLA .81 .77 .85 .98 1.35 1.96 1.86
ATP 1.09 .92 .83 .90 1.19 1.63 1.12
KLA/ATP .83 .72 .90 .94 .92 1.64 3.46
Pycard
KLA  ATP  ATP+KLA
 NM_023258 PYD and CARD domain containing (Pycard), mRNA [NM_023258] KLA 1.48 1.44 1.62 1.81 1.80 1.69 .94
ATP .89 .88 1.00 .84 .52 .30 .62
KLA/ATP 1.32 1.34 1.65 1.38 1.14 .50 .41
Rab1
KLA  ATP  ATP+KLA
 NM_008996 RAB1, member RAS oncogene family (Rab1), mRNA [NM_008996] KLA 1.25 1.21 1.49 1.54 1.78 1.58 1.14
ATP 1.01 .85 .50 .57 1.07 1.29 1.09
KLA/ATP 1.25 1.12 .84 .84 1.32 1.69 1.15
Rab1b
KLA  ATP  ATP+KLA
 NM_029576 RAB1B, member RAS oncogene family (Rab1b), mRNA [NM_029576] KLA .81 .83 .82 .73 .78 .77 .95
ATP 1.01 1.17 1.13 1.49 1.09 .77 1.13
KLA/ATP .84 .92 .69 1.08 .72 .79 .98
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Sar1a
KLA  ATP  ATP+KLA
 NM_009120 SAR1 gene homolog A (S. cerevisiae) (Sar1a), mRNA [NM_009120] KLA 1.66 1.79 1.74 1.76 1.68 1.55 1.50
ATP 1.00 .92 1.03 1.06 1.54 2.40 2.04
KLA/ATP 1.76 1.85 1.67 1.85 1.98 2.32 3.21
Sar1b
KLA  ATP  ATP+KLA
 NM_025535 SAR1 gene homolog B (S. cerevisiae) (Sar1b), mRNA [NM_025535] KLA 1.22 1.22 1.22 1.25 1.16 1.20 1.31
ATP 1.03 1.07 1.22 1.21 1.20 1.02 1.15
KLA/ATP 1.32 1.17 1.22 1.22 1.15 1.12 1.09
Sec22b
KLA  ATP  ATP+KLA
 NM_011342 SEC22 vesicle trafficking protein homolog B (S. cerevisiae) (Sec22b), mRNA [NM_011342] KLA 1.18 1.18 1.22 1.35 1.29 1.23 1.19
ATP 1.06 1.03 1.09 1.02 1.34 2.84 1.53
KLA/ATP 1.17 1.27 1.42 1.29 1.28 1.69 1.90
Tlr2
KLA  ATP  ATP+KLA
 NM_011905 toll-like receptor 2 (Tlr2), mRNA [NM_011905] KLA 13.65 11.82 8.87 7.95 4.67 2.78 2.33
ATP 1.06 1.24 2.76 6.28 11.55 13.82 .67
KLA/ATP 13.11 12.91 14.48 13.84 14.18 11.14 2.78
Tlr4
KLA  ATP  ATP+KLA
 NM_021297 toll-like receptor 4 (Tlr4), mRNA [NM_021297] KLA .69 .61 .75 .94 .64 .81 .73
ATP .95 .90 1.12 .56 .47 1.51 1.53
KLA/ATP .57 .62 1.01 .64 .39 .73 1.13
Tlr5
KLA  ATP  ATP+KLA
 AF186107 toll-like receptor 5 (Tlr5) mRNA, complete cds [AF186107] KLA .78 .75 .84 .78 .72 .74 .43
ATP .98 1.07 .99 .95 .79 .66 .61
KLA/ATP .79 .81 .77 .73 .73 .67 .50
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07
Vcp
KLA  ATP  ATP+KLA
 NM_009503 valosin containing protein (Vcp), mRNA [NM_009503] KLA .89 .99 .95 .88 .92 .97 1.04
ATP 1.03 1.02 .80 .71 1.05 1.42 .74
KLA/ATP .99 1.02 .79 .71 .85 1.05 .65